Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6175749 | 0.86 | CCKBR (0.48) | CCKBRCCKAR | |
| SCHEMBL6176974 | 0.86 | CCKBR (0.53) | CCKBRCCKAR | |
| SCHEMBL6176695 | 0.83 | CCKBR (0.51) | CCKBRCCKAR | |
| SCHEMBL6179274 | 0.82 | CCKBR (0.52) | CCKBRCCKAR | |
| SCHEMBL6178211 | 0.82 | CCKBR (0.52) | CCKBRCCKAR | |
| SCHEMBL6179974 | 0.81 | CCKBR (0.58) | CCKBRCCKAR | |
| SCHEMBL6179566 | 0.80 | CCKBR (0.47) | CCKBRCCKAR | |
| SCHEMBL6176942 | 0.80 | CCKBR (0.44) | CCKBRCCKAR | |
| SCHEMBL6177837 | 0.79 | CCKBR (0.54) | CCKBR | |
| SCHEMBL6180216 | 0.79 | CCKBR (0.50) | CCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |